Abbott (NYSE: ABT) reported Q4 EPS of $1.34, in-line with the analyst estimate of $1.34. Revenue for the quarter came in at $10.97 billion versus the consensus estimate of $11.03 billion.

GUIDANCE:

Abbott sees FY2025 EPS of $5.05-$5.25, versus the consensus of $5.16.

Abbott projects full-year 2025 organic sales growth to be in the range of 7.5% to 8.5%.

Abbott projects full-year 2025 adjusted operating margin to be 23.5% to 24.0% of sales.

For earnings history and earnings-related data on Abbott (ABT) click here.